List of Devices Companies in Japan - 7

Pharmaceuticals, diagnostic reagents, medical devices

The HORIBA Group of worldwide companies provides an extensive array of instruments and systems for applications ranging from automotive R&D, process and environmental monitoring, in-vitro medical diagnostics, semiconductor manufacturing and metrology, to a broad range of scientific R&D and QC measurements. Proven quality and trustworthy performance have established widespread confidence in the HORIBA Brand.

Nobelpharma - “Contribute to Society by Providing Critical but Neglected Pharmaceuticals and Medical Devices” This has remained Nobelpharma’s company mission since we were founded in 2003. “Critical but neglected pharmaceuticals and medical devices” refers to the drugs and medical devices that are not being actively developed by existing pharmaceutical companies because there are only a few patients that require them and thus less viable as a business. At the time of our founding, there were new pharmaceutical candidates (curative drugs) which were already available or under development overseas with confirmed efficacy. However, the patients in Japan were unable to use them. We wanted to resolve this situation (so-called drug lag) ourselves, and deliver these drugs to patients as soon as possible. Nobelpharma was born with such strong will, taking the initiative in responding the issue of unapproved and off-label drugs with high medical needs.

Solasia Pharma - ‘Sol’ means the Sun and ‘Asia’ the Asian counties in Spanish. We desire to be the Sun brightening the future of various people facing many challenges of cancers in Japan and other Asian countries.

Teijin is a technology-driven global group with two core businesses: high-performance materials and healthcare solutions. Established in 1918 as Japan's first rayon manufacturer, Teijin today comprises some 170 companies employing 20,000 people in 20 countries. Through our purpose of "Pioneering Solutions Togeher for a Healthy Planet". Teijin relentlessly strives to aims to be a company that supports the society of the future by protecting the global environment and addressing the needs of people and communities. Teijin posted consolidated sales of JPY 1,032.8 billion (USD 6.6 billion) and total assets of JPY 1,251.0 billion (USD 8.0 billion) in the fiscal year ending March 31, 2024.

Pharmaceutical company focusing on transdermal DDS technology and pain relief therapeutic field

At Zeria,our business is based on a set of guiding principles we call the Z・E・R・I・A　Five Corporate Spirits. Zoom in on healthcare Excel in quality at every level Reach out to the world Inspire confidence in management Achieve our potential